Cochrane · systematic review · CD011296

Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus

Colunga‐Lozano, LE, Gonzalez Torres, FJ, Delgado‐Figueroa, N, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
2
Included studies
NR
No studies 2 · 28.6%Ungraded 0 · 0%Very low 3 · 42.9%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus

Population: non‐critically ill hospitalised adults with diabetes mellitus
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality (N)
Sliding scale insulin vs basal‐bolus insulin
Peto OR 0.5 [0.05, 4.85]4 studies · 602 participantsLow
Downgraded: imprecision
Diabetes‐related morbidity
Sliding scale insulin vs basal‐bolus insulin
no estimate extractedNRNo studies
Severe hypoglycaemic episodes (N)
Sliding scale insulin vs basal‐bolus insulin
RR 0.22 [0.05, 1]5 studies · 667 participantsVery low
Downgraded: risk of bias, imprecision
Length of hospital stay (days)
Sliding scale insulin vs basal‐bolus insulin
no estimate extracted6 studies · 717 participantsVery low
Downgraded: imprecision, inconsistency
Adverse events other than hypoglycaemic episodes (postoperative complications, mainly infectious) (N)
Sliding scale insulin vs basal‐bolus insulin
RR 1.16 [0.25, 5.37]3 studies · 481 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Mean glucose level (mg/dL (mmol/L))
Sliding scale insulin vs basal‐bolus insulin
no estimate extracted6 studies · 717 participantsLow
Downgraded: risk of bias, imprecision
Socioeconomic effects
Sliding scale insulin vs basal‐bolus insulin
no estimate extractedNRNo studies